This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Ciaran S. Phibbs, PhD; David A. Bateman, MD; Rachel M. Schwartz, MPH
Veterans Affairs Medical Center Palo Alto, Calif

JAMA. 1992;267(4):507-508.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.

—Dr Page is correct in pointing out that our abstract was potentially misleading. Our article examined both the crude (or unadjusted) costs of fetal cocaine exposure and those obtained from regression models. In the abstract we included only the unadjusted costs and the most interesting regression results, ie, the differential effects of crack and multiple substance exposure. We regret not clearly stating in the abstract the method by which each of these was calculated; however, as Page notes, we did so in the body of the article.

However, Page's objections to our national projections are unfounded because the projections were based on a regression model where the cost of cocaine was statistically significant (model 3, the effects of crack vs other forms of cocaine exposure). His conclusions about the lack of statistical significance of the variable for all cocaine-exposed infants (model 1) deserves comment. Although it did not . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?